Lundbeck's 2014 half-yearly and second quarter results are now released.
See webcast of the investor presentation.
We operate in more than 57 countries around the world. If your country is not on the list, please refer to our global contacts.
Interested in becoming part of top-tier neuroscience research?
Progress in Mind is Lundbeck’s dedication to addressing the global burden of brain disease.
The number one obstacle to better mental health care is the stigmatization of people with mental illness. And stigmatization occurs on every level of society, according to psychiatrist Norman Sartorius.
In recent years, researchers have taken important steps towards understanding how brain diseases develop and why they evolve the way they do. This knowledge may lead to new and improved treatments – which gives renewed hope to patients and their families.
at 16:59 118.3 DKK -0.755%
The Lundbeck Magazine portrays true patient stories and reviews the stigma surrounding people living with brain disease.Read the latest edition.
Current open positions